Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units
Author:
Open Access
- 1 January 2008
- journal article
- review article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 14 (1) , 5-13
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- APPROPRIATE AND TIMELY EMPIRICAL ANTIMICROBIAL TREATMENT OF ICU INFECTIONS - A ROLE FOR CARBAPENEMSActa Clinica Belgica, 2005
- The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital ChargesInfection Control & Hospital Epidemiology, 2005
- Management of Invasive Candidiasis in Critically Ill PatientsDrugs, 2004
- Appropriate Empirical Antibacterial Therapy for Nosocomial InfectionsDrugs, 2003
- Health and Economic Outcomes of Vancomycin-Resistant EnterococciArchives of internal medicine (1960), 2002
- Controlling Antimicrobial Resistance in Hospitals: Infection Control and Use of AntibioticsEmerging Infectious Diseases, 2001
- ANTIMICROBIAL RESISTANCE IN INTENSIVE CARE UNITSClinics in Chest Medicine, 1999
- Risk Factors and Outcome of Nosocomial Infections: Results of a Matched Case-control Study of ICU PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- The Prevalence of Nosocomial Infection in Intensive Care Units in EuropeJAMA, 1995
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991